𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of cyclosporin A on active Crohn’s disease

✍ Scribed by Fukushima, Tsuneo ;Sugita, Akira ;Masuzawa, Shigeyuki ;Yamazaki, Yasunobu ;Tsuchiya, Shuji


Book ID
110680145
Publisher
Springer-Verlag
Year
1989
Tongue
English
Weight
270 KB
Volume
24
Category
Article
ISSN
0435-1339

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Treatment of Crohn's disease in relapse
✍ Mr. N. R. Parrott; R. M. R. Taylor; C. W. Venables; C. O. Record 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 3 views

It has been suggested that cyclosporin A might be of some benefit to patients with Crohn's disease. The clinical response and side-effects of cyclosporin A in Crohn's disease are described in a series of 13 adults. The majority of patients had ileal disease and all but one were started on an initial

Effects of active and passive smoking on
✍ Frans van der Heide; Arie Dijkstra; Rinse K. Weersma; Frans A. Albersnagel; Elis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Background: Smoking is a remarkable risk factor for inflammatory bowel disease (ibd), aggravating crohn's disease (cd) while having beneficial effects on ulcerative colitis (uc). we studied the effects of active and passive smoking in dutch ibd patients. ## Methods: A questionnaire focusing on

Severe bone pain as an adverse effect of
✍ Dr. Kim L. Isaacs 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

A case of severe bone pain associated with cyclosporin therapy for Crohn's disease is reported. Severe leg pain developed in a 32-year-old man who was receiving cyclosporin for Crohn's disease that was refractory to medical management. Leg pain was related to the dose of cyclosporin, improved with c

Effect of low-dose cyclosporin a on syst
✍ Michiaki Tokuda; Noriyuki Kurata; Akihito Mizoguchi; Masayuki Inoh; Kunio Seto; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 709 KB

Objective. To determine the effect of low-dose cyclosporin A (CSA) treatment on disease activity in systemic lupus erythematosus (SLE). Methods. All patients in the study had active disease as defined by at least the presence of a low CH50 level. Patients were initially given 3 mg/kg/day of CSA. Do